C
Aurinia Pharmaceuticals Inc. AUPH
$12.26 $0.181.49% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 70.01M 62.47M 59.87M 67.77M 57.19M
Total Other Revenue -- -- -- -- --
Total Revenue 70.01M 62.47M 59.87M 67.77M 57.19M
Cost of Revenue 14.55M 14.32M 13.66M 9.08M 12.99M
Gross Profit 55.46M 48.15M 46.21M 58.69M 44.20M
SG&A Expenses 26.02M 20.34M 37.03M 42.37M 44.93M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 9.25M 4.43M 1.39M 4.57M -290.00K
Total Operating Expenses 49.81M 39.09M 52.09M 56.02M 57.63M
Operating Income 20.20M 23.38M 7.78M 11.75M -441.00K
Income Before Tax 22.16M 24.35M 1.17M 14.81M 1.48M
Income Tax Expenses 643.00K 1.01M -256.00K 457.00K 756.00K
Earnings from Continuing Operations 21.51M 23.34M 1.43M 14.35M 722.00K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 21.51M 23.34M 1.43M 14.35M 722.00K
EBIT 20.20M 23.38M 7.78M 11.75M -441.00K
EBITDA 25.06M 28.24M 12.64M 16.64M 4.40M
EPS Basic 0.16 0.17 0.01 0.10 0.01
Normalized Basic EPS 0.10 0.12 0.07 0.06 0.01
EPS Diluted 0.16 0.16 0.01 0.10 0.01
Normalized Diluted EPS 0.10 0.11 0.07 0.06 0.01
Average Basic Shares Outstanding 134.87M 138.92M 142.18M 143.05M 143.33M
Average Diluted Shares Outstanding 137.53M 143.20M 147.68M 145.65M 144.11M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --